Home LiteratureArticle Details
PMID: 16102441 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Transcript signatures of lymphocytic bronchitis in lung allograft biopsy specimens.

Xu X, Golden JA, Dolganov G, Jones KD, Donnelly S, Weaver T, Caughey GH

Abstract

Rejection and obliterative bronchiolitis are barriers to sustained graft function in recipients of transplanted lungs. Early detection is hindered by inadequate tests and an incomplete understanding of the molecular events preceding or accompanying graft deterioration. Hypothesizing that genes involved in immune responses and tissue remodeling produce biomarkers of rejection, we measured the expression of 192 selected genes in 72 sets of biopsy specimens from human lung allografts. Gene transcripts were quantified using a 2-step, multiplex, real-time polymerase chain reaction approach in endobronchial and transbronchial biopsy specimens from transplant recipients without acute infections undergoing routine surveillance bronchoscopy. Comparisons of histopathology in parallel biopsy specimens identified 6 genes correlating with rejection as manifested by lymphocytic bronchitis, a suspected harbinger of obliterative bronchiolitis. For example, beta2-defensin and collagenase transcripts in inflamed bronchi increased 37-fold and 163-fold, respectively. By contrast, these transcripts did not correlate with acute rejection in transbronchial specimens. Further, no correspondence was noted between histopathologic bronchitis and parenchymal rejection when endobronchial and transbronchial samples were obtained from the same patient. Our highly sensitive method permits quantitation of many gene transcripts simultaneously in small, bronchoscopically acquired biopsy specimens of allografts. Transcript signatures obtained by this approach suggest that airway and alveolar responses to rejection differ and that endobronchial biopsy specimens assess lymphocytic bronchitis and chronic rejection but are not proxies for transbronchial biopsy specimens. Further, they reveal changes in airway expression of the specific genes involved in host defense and remodeling and suggest that the measurement of transcripts correlating with lymphocytic bronchitis may be diagnostic adjuncts to histopathology.

MeSH Terms
Adult Biopsy, Needle Bronchiolitis Obliterans/pathology Bronchoscopy Cohort Studies Female Gene Expression Profiling Gene Expression Regulation Genetic Markers/genetics Graft Rejection/pathology Humans Immunohistochemistry Lung Transplantation/adverse effects,methods Lymphocyte Activation Male Middle Aged Polymerase Chain Reaction Prognosis RNA Stability/genetics Sensitivity and Specificity Transplantation, Homologous
Chemicals
Genetic Markers
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Xu Xiang
Department of Medicine University of California at San Francisco, San Francisco, 94143, USA.
Golden Jeffrey A
Dolganov Gregory
Jones Kirk D
Donnelly Samantha
Weaver Timothy
Caughey George H
References (39)
39 references, click to expand
  1. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase.
    J Immunol. 2001 Feb 15;166(4):2783-92 PMID: 11160345
  2. Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection.
    Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1822-8 PMID: 9620912
  3. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression.
    Am J Respir Crit Care Med. 2001 Feb;163(2):517-23 PMID: 11179133
  4. Lung transplantation at the turn of the century.
    Annu Rev Med. 2001;52:185-201 PMID: 11160774
  5. Current trends in lung transplantation.
    Am J Transplant. 2001 Sep;1(3):204-10 PMID: 12102253
  6. Airway versus transbronchial biopsy and BAL in lung transplant recipients: different but complementary.
    Eur Respir J. 1997 Dec;10(12):2876-80 PMID: 9493677
  7. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
    Genome Biol. 2002 Jun 18;3(7):RESEARCH0034 PMID: 12184808
  8. Leukotrienes and airway responses.
    Am Rev Respir Dis. 1987 Oct;136(4):985-98 PMID: 2821857
  9. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome.
    Ann Thorac Surg. 2002 Apr;73(4):1041-7; discussion 1047-8 PMID: 11996238
  10. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
    J Thorac Cardiovasc Surg. 1997 Aug;114(2):195-202 PMID: 9270635
  11. Obliterative airway disease progresses in heterotopic airway allografts without persistent alloimmune stimulus.
    Transplantation. 2002 Aug 27;74(4):557-62 PMID: 12352919
  12. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.
    N Engl J Med. 2003 Jul 10;349(2):125-38 PMID: 12853585
  13. Obliterative bronchiolitis after lung and heart-lung transplantation.
    Ann Thorac Surg. 1995 Dec;60(6):1845-53 PMID: 8787504
  14. Bronchoalveolar lavage(BAL) neutrophilia in lung transplant recipients(LTR): infection and bronchiolitis obliterans syndrome(BOS), the chicken or the egg?
    J Heart Lung Transplant. 2001 Feb;20(2):260 PMID: 11250525
  15. The utility of open lung biopsy following lung transplantation.
    J Heart Lung Transplant. 2000 Sep;19(9):852-7 PMID: 11008074
  16. The role of innate immunity in acute allograft rejection after lung transplantation.
    Am J Respir Crit Care Med. 2003 Sep 15;168(6):628-32 PMID: 12773319
  17. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
    J Heart Lung Transplant. 1996 Dec;15(12):1200-8 PMID: 8981205
  18. Acute rejection following lung transplantation: limitations in accuracy of thin-section CT for diagnosis.
    Radiology. 2001 Oct;221(1):207-12 PMID: 11568342
  19. Gene expression patterns in lung rejection.
    Transplant Proc. 2001 Nov-Dec;33(7-8):3566-7 PMID: 11750517
  20. Respiratory viruses and chronic rejection in lung transplant recipients.
    J Heart Lung Transplant. 2002 May;21(5):559-66 PMID: 11983546
  21. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?
    J Heart Lung Transplant. 2002 Jun;21(6):658-66 PMID: 12057699
  22. Production of beta-defensins by human airway epithelia.
    Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14961-6 PMID: 9843998
  23. Bronchiolitis obliterans syndrome in heart-lung transplant recipients: diagnosis with expiratory CT.
    Radiology. 2001 Feb;218(2):533-9 PMID: 11161175
  24. Gene expression profiling of bronchoalveolar lavage cells in acute lung rejection.
    Am J Respir Crit Care Med. 2003 Nov 15;168(10):1237-42 PMID: 12958056
  25. A novel method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na+-K+-Cl- cotransporter (NKCC1) in asthmatic subjects.
    Genome Res. 2001 Sep;11(9):1473-83 PMID: 11544191
  26. Prediction of rejection in lung transplantation.
    Transplant Proc. 2001 Feb-Mar;33(1-2):291-2 PMID: 11266823
  27. Mammalian defensins in immunity: more than just microbicidal.
    Trends Immunol. 2002 Jun;23(6):291-6 PMID: 12072367
  28. Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis.
    Am J Respir Crit Care Med. 2003 Oct 1;168(7):770-8 PMID: 12816739
  29. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.
    J Heart Lung Transplant. 2002 Mar;21(3):297-310 PMID: 11897517
  30. Methods for the assessment of endobronchial biopsies in clinical research: application to studies of pathogenesis and the effects of treatment.
    Am J Respir Crit Care Med. 2003 Sep 15;168(6 Pt 2):S1-17 PMID: 14555461
  31. Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/SCYA18.
    Genomics. 1999 Mar 15;56(3):296-302 PMID: 10087196
  32. Internet-based home monitoring of pulmonary function after lung transplantation.
    Am J Respir Crit Care Med. 2002 Mar 1;165(5):694-7 PMID: 11874816
  33. Contrasting response of lung parenchymal cells to instilled TNF alpha and IFN gamma: the inducibility of specific cell ICAM-1 in vivo.
    Am J Respir Cell Mol Biol. 1996 Oct;15(4):540-50 PMID: 8879188
  34. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients.
    J Heart Lung Transplant. 2002 Oct;21(10):1062-7 PMID: 12398870
  35. Risk factors for bronchiolitis obliterans: a systematic review of recent publications.
    J Heart Lung Transplant. 2002 Feb;21(2):271-81 PMID: 11834356
  36. Human allogeneic CD2+ lymphocytes activate airway-derived epithelial cells to produce interleukin-6 and interleukin-8. Possible role for the epithelium in chronic allograft rejection.
    J Heart Lung Transplant. 2002 May;21(5):567-75 PMID: 11983547
  37. Analysis of risk factors for the development of bronchiolitis obliterans syndrome.
    Am J Respir Crit Care Med. 1999 Mar;159(3):829-33 PMID: 10051258
  38. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group.
    J Heart Lung Transplant. 1996 Jan;15(1 Pt 1):1-15 PMID: 8820078
  39. Improved results after heart-lung transplantation: a 17-year experience.
    Transplantation. 2003 Jan 15;75(1):127-32 PMID: 12544884
Article Info
Journal
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Abbr.
J Heart Lung Transplant
ISSN
1053-2498
Published
2005-08-00
Pages
1055-66
Language
English
Region
United States
NLM ID
9102703
PMCID
PMC2271113
Subset
IM
Grants
NHLBI NIH HHS · P01 HL024136-220014 · United States
NHLBI NIH HHS · P01 HL024136-230014 · United States
NHLBI NIH HHS · P01 HL024136 · United States
NHLBI NIH HHS · P01 HL024136-22 · United States
NHLBI NIH HHS · HL024136 · United States
NHLBI NIH HHS · P01 HL024136-26 · United States
NHLBI NIH HHS · P01 HL024136-23 · United States
NHLBI NIH HHS · P01 HL024136-24 · United States
NHLBI NIH HHS · P01 HL024136-260002 · United States
NHLBI NIH HHS · P01 HL024136-240014 · United States
NHLBI NIH HHS · P01 HL024136-25 · United States
NHLBI NIH HHS · P01 HL024136-250014 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]